Sort
53,477 grants matching “addiction”
Genetics of Opioid Dependence
$1,062,418Joel Gelernter · Yale University · R01 · FY2007 · DA
Neurobiology of Substance Abuse and Addiction
$1,062,000Nora D. Volkow · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models
$1,061,312Richard Saitz · Boston Medical Center · R01 · FY2008 · DA
Brain Temperature, Reward, And Drugs Of Abuse
$1,061,074Eugene A Kiyatkin · National Institute On Drug Abuse · ZIA · FY2009 · DA
Clinical advancement of RDC-0313-buprenorphine: a novel approach to opioid recep
$1,061,000Ryan Turncliff · Alkermes, Inc. · R01 · FY2010 · DA
Targeting Nrf2 for Cancer Chemoprevention
$1,060,913Thomas W Kensler · Fred Hutchinson Cancer Research Center · R35 · FY2018 · CA
Development of cutting-edge optical imaging systems for in vivo imaging in live animals
$1,060,683Da-Ting Lin · National Institute On Drug Abuse · ZIC · FY2016 · DA
In vivo imaging of dorsal striatum function in freely behaving mice
$1,060,683Da-Ting Lin · National Institute On Drug Abuse · ZIA · FY2016 · DA
Effectiveness of Extended Treatments for Drug Dependence
$1,059,107James R McKay · University Of Pennsylvania · R01 · FY2009 · DA
The UIUC Neuroproteomics Center on Cell-Cell Signaling
$1,059,091University Of Illinois Urbana-Champaign · P30 · FY2004 · DA
ADRD risk and resilience among Black Americans: A 20-year longitudinal study
$1,059,015Briana Mezuk · University Of Michigan At Ann Arbor · R01 · FY2025 · AG
Characterization of Molecular Pathways in Chronic Pain Conditions
$1,058,562Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
VA Cooperative Studies Program Coordinating Center
$1,058,542National Institute On Drug Abuse · Y01 · FY2020 · DA
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,057,469Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$1,057,333Douglas K Owens · Stanford University · R37 · FY2021 · DA
Pharmacology and toxicology of newly-emerging designer drugs of abuse
$1,057,325Michael Baumann · National Institute On Drug Abuse · ZIA · FY2016 · DA
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION
$1,057,197Rockefeller University · R01 · FY2001 · DA
'Differential Effects of Methamphetamine and Cocaine
$1,056,581University Of Utah · P01 · FY2005 · DA
Comprehensive, tailored, technology-based intervention to improve virologic suppression among youth and young adults living with HIV
$1,056,159Parya Saberi · University Of California, San Francisco · R01 · FY2023 · MH
Staged Low-Barrier and Mobile Care to Improve Retention and Viral Suppression in Hard-To-Reach Vulnerable People Living With HIV
$1,056,127Katerina A Christopoulos · University Of California, San Francisco · R01 · FY2022 · AI
A staged, comprehensive investigation for developing insular deep brain stimulation to treat refractory chronic pain
$1,056,031William Jeffrey Elias · University Of Virginia · UH3 · FY2022 · NS
Clinical Trials Network: Greater New York Node
$1,055,724Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2011 · DA
Florida Node of The Drug Abuse Clinical Trials Network
$1,055,478Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2007 · DA
The UIUC Neuroproteomics Center on Cell-Cell Signaling
$1,055,072Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2006 · DA
COBRE PHASE III: Center for Neuroplasticity at the University of Puerto Rico
$1,054,473Jose A Lasalde-Dominicci · University Of Puerto Rico Med Sciences · P30 · FY2025 · GM